Ensysce Biosciences, Inc. Net Income Loss

Quick Answer

Ensysce Biosciences, Inc. reported Net Income Loss of $2.40 million for the year ending 2020.

  • Ensysce Biosciences, Inc. showed an increase of +557.1% in Net Income Loss from 2019 to 2020.
  • This data is from Ensysce Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 15, 2021.
  • XBRL data for this metric is available from 2018 to 2020 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2018 to 2020), Ensysce Biosciences, Inc.'s Net Income Loss has grown by 13.3%.
  • Historical annual values: Fiscal year 2020: $2.40 million | Fiscal year 2019: $366.0 thousand | Fiscal year 2018: $2.12 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: